Challenges identifying efficacious miRNA therapeutics for cancer
Meirav SegalHMS Initiative for RNA Medicine, Department of Pathology, Beth, Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USAFrank J. SlackHMS Initiative for RNA Medicine, Department of Pathology, Beth, Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA
2020en
ABI
Аннотация
MicroRNAs are a class of small non-coding RNAs (22–23 nucleotides), which regulate gene expression at the post-transcriptional level and play key roles in tumorigenesis and other diseases [1,2]. Mi...
Ҳали таржима қилинмаган
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба